FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA has approved a supplemental application for Cardizem CD (diltiazem hydrochloride) filed by Bausch Health US LLC under NDA 020062.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Stable Angina
• Supraventricular Tachycardia

Drugs mentioned

• Cardizem CD (Diltiazem hydrochloride)

Snippet

SUPPL AP for CARDIZEM CD (DILTIAZEM HYDROCHLORIDE)